SIGA Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-26 | 2022 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 869,456 | 869,456 | 0 | 0 | 0 | 1,738,912 |
| 2023-04-26 | 2020 | Robin E. Abrams Former General Counsel and Chief Administrative Officer | 551,499 | 551,499 | 0 | 0 | 0 | 1,102,998 |
| 2023-04-26 | 2021 | Robin E. Abrams Former General Counsel and Chief Administrative Officer | 619,544 | 619,544 | 0 | 0 | 0 | 1,239,088 |
| 2023-04-26 | 2022 | Robin E. Abrams Former General Counsel and Chief Administrative Officer | 186,121 | 0 | 0 | 0 | 0 | 186,121 |
| 2023-04-26 | 2020 | Dennis E. Hruby, Ph.D. Executive Vice President & Chief Scientific Officer | 633,386 | 633,386 | 0 | 200,000 | 0 | 1,466,772 |
| 2023-04-26 | 2021 | Dennis E. Hruby, Ph.D. Executive Vice President & Chief Scientific Officer | 652,388 | 652,388 | 0 | 0 | 0 | 1,304,776 |
| 2023-04-26 | 2022 | Dennis E. Hruby, Ph.D. Executive Vice President & Chief Scientific Officer | 671,960 | 739,156 | 0 | 0 | 0 | 1,411,116 |
| 2023-04-26 | 2020 | Daniel J. Luckshire Executive Vice President, & Chief Financial Officer | 636,540 | 636,540 | 0 | 0 | 0 | 1,273,080 |
| 2023-04-26 | 2021 | Daniel J. Luckshire Executive Vice President, & Chief Financial Officer | 655,636 | 655,636 | 0 | 0 | 0 | 1,311,272 |
| 2023-04-26 | 2022 | Daniel J. Luckshire Executive Vice President, & Chief Financial Officer | 675,305 | 709,070 | 0 | 0 | 0 | 1,384,375 |
| 2023-04-26 | 2020 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 819,545 | 819,545 | 0 | 0 | 0 | 1,639,090 |
| 2023-04-26 | 2021 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 844,132 | 844,132 | 0 | 0 | 0 | 1,688,264 |
| 2022-04-27 | 2021 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 844,132 | 844,132 | 0 | 0 | 0 | 1,688,264 |
| 2022-04-27 | 2020 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 819,545 | 819,545 | 0 | 0 | 0 | 1,639,090 |
| 2022-04-27 | 2019 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 795,675 | 795,675 | 0 | 0 | 0 | 1,591,350 |
| 2022-04-27 | 2021 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 655,636 | 655,636 | 0 | 0 | 0 | 1,311,272 |
| 2022-04-27 | 2020 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 636,540 | 636,540 | 0 | 0 | 0 | 1,273,080 |
| 2022-04-27 | 2019 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 618,000 | 618,000 | 448,000 | 0 | 0 | 1,684,000 |
| 2022-04-27 | 2021 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 652,388 | 652,388 | 0 | 0 | 0 | 1,304,776 |
| 2022-04-27 | 2020 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 633,386 | 633,386 | 0 | 200,000 | 0 | 1,466,772 |
| 2022-04-27 | 2019 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 614,938 | 614,938 | 0 | 200,000 | 0 | 1,429,876 |
| 2022-04-27 | 2021 | Robin E. Abrams General Counsel and Chief Administrative Officer | 619,544 | 619,544 | 0 | 0 | 0 | 1,239,088 |
| 2022-04-27 | 2020 | Robin E. Abrams General Counsel and Chief Administrative Officer | 551,499 | 551,499 | 0 | 0 | 0 | 1,102,998 |
| 2022-04-27 | 2019 | Robin E. Abrams General Counsel and Chief Administrative Officer | 535,436 | 535,436 | 448,000 | 0 | 0 | 1,518,872 |
| 2021-04-27 | 2020 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 819,545 | 819,545 | 0 | 0 | 0 | 1,639,090 |
| 2021-04-27 | 2019 | Robin E. Abrams General Counsel and Chief Administrative Officer | 535,436 | 535,436 | 448,000 | 0 | 0 | 1,518,872 |
| 2021-04-27 | 2020 | Robin E. Abrams General Counsel and Chief Administrative Officer | 551,499 | 551,499 | 0 | 0 | 0 | 1,102,998 |
| 2021-04-27 | 2018 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 597,027 | 597,027 | 0 | 0 | 0 | 1,194,054 |
| 2021-04-27 | 2019 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 614,938 | 614,938 | 0 | 200,000 | 0 | 1,429,876 |
| 2021-04-27 | 2020 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 633,386 | 633,386 | 0 | 200,000 | 0 | 1,466,772 |
| 2021-04-27 | 2018 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 600,000 | 600,000 | 0 | 0 | 0 | 1,200,000 |
| 2021-04-27 | 2019 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 618,000 | 618,000 | 448,000 | 0 | 0 | 1,684,000 |
| 2021-04-27 | 2020 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 636,540 | 636,540 | 0 | 0 | 0 | 1,273,080 |
| 2021-04-27 | 2018 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 772,500 | 772,500 | 0 | 0 | 0 | 1,545,000 |
| 2021-04-27 | 2019 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 795,675 | 795,675 | 0 | 0 | 0 | 1,591,350 |
| 2021-04-27 | 2018 | Robin E. Abrams General Counsel and Chief Administrative Officer | 519,841 | 519,841 | 119,700 | 0 | 0 | 1,159,382 |
| 2020-04-28 | 2018 | Robin E. Abrams General Counsel and Chief Administrative Officer | 519,841 | 519,841 | 119,700 | 0 | 0 | 1,159,382 |
| 2020-04-28 | 2019 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 795,675 | 795,675 | 0 | 0 | 0 | 1,591,350 |
| 2020-04-28 | 2018 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 772,500 | 772,500 | 0 | 0 | 0 | 1,545,000 |
| 2020-04-28 | 2017 | Phillip L. Gomez, Ph.D. Chief Executive Officer | 750,000 | 912,329 | 0 | 0 | 0 | 1,662,329 |
| 2020-04-28 | 2019 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 618,000 | 618,000 | 448,000 | 0 | 0 | 1,684,000 |
| 2020-04-28 | 2018 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 600,000 | 600,000 | 0 | 0 | 0 | 1,200,000 |
| 2020-04-28 | 2017 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 521,674 | 521,674 | 0 | 0 | 0 | 1,043,348 |
| 2020-04-28 | 2019 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 614,938 | 614,938 | 0 | 200,000 | 0 | 1,429,876 |
| 2020-04-28 | 2018 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 597,027 | 597,027 | 0 | 0 | 0 | 1,194,054 |
| 2020-04-28 | 2017 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 579,638 | 579,638 | 88,000 | 0 | 0 | 1,247,276 |
| 2020-04-28 | 2019 | Robin E. Abrams General Counsel and Chief Administrative Officer | 535,436 | 535,436 | 448,000 | 0 | 0 | 1,518,872 |
| 2020-04-28 | 2017 | Robin E. Abrams General Counsel and Chief Administrative Officer | 504,700 | 504,700 | 0 | 0 | 0 | 1,009,400 |
| 2019-04-29 | 2017 | Eric A. Rose, M.D. Executive Chairman of the Board (until October 13, 2018) Chief Executive Officer (until October 13, 2016) | 732,167 | 0 | 0 | 0 | 0 | 732,167 |
| 2019-04-29 | 2018 | Eric A. Rose, M.D. Executive Chairman of the Board (until October 13, 2018) Chief Executive Officer (until October 13, 2016) | 551,932 | 0 | 0 | 0 | 42,935 | 594,867 |
| 2019-04-29 | 2016 | Robin E. Abrams General Counsel and Chief Administrative Officer (effective April 12, 2016) | 426,894 | 490,000 | 0 | 0 | 0 | 916,894 |
| 2019-04-29 | 2018 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 600,000 | 600,000 | 0 | 0 | 0 | 1,200,000 |
| 2019-04-29 | 2016 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 162,500 | 0 | 2,108,824 | 0 | 0 | 2,271,324 |
| 2019-04-29 | 2017 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 750,000 | 912,329 | 0 | 0 | 0 | 1,662,329 |
| 2019-04-29 | 2018 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 597,027 | 597,027 | 0 | 0 | 0 | 1,194,054 |
| 2019-04-29 | 2016 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 506,480 | 1,178,304 | 0 | 0 | 0 | 1,684,784 |
| 2019-04-29 | 2017 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 521,674 | 521,674 | 0 | 0 | 0 | 1,043,348 |
| 2019-04-29 | 2018 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 772,500 | 772,500 | 0 | 0 | 0 | 1,545,000 |
| 2019-04-29 | 2018 | Robin E. Abrams General Counsel and Chief Administrative Officer (effective April 12, 2016) | 519,841 | 519,841 | 119,700 | 0 | 0 | 1,159,382 |
| 2019-04-29 | 2016 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 562,755 | 1,414,571 | 0 | 0 | 0 | 1,977,326 |
| 2019-04-29 | 2017 | Robin E. Abrams General Counsel and Chief Administrative Officer (effective April 12, 2016) | 504,700 | 504,700 | 0 | 0 | 0 | 1,009,400 |
| 2019-04-29 | 2017 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 579,638 | 579,638 | 88,000 | 0 | 0 | 1,247,276 |
| 2019-04-29 | 2016 | Eric A. Rose, M.D. Executive Chairman of the Board (until October 13, 2018) Chief Executive Officer (until October 13, 2016) | 778,386 | 1,442,516 | 717,000 | 0 | 0 | 2,937,902 |
| 2018-04-18 | 2017 | Robin A. Abrams General Counsel and Chief Administrative Officer (effective April 12, 2016) | 504,700 | 504,700 | 0 | 0 | 0 | 1,009,400 |
| 2018-04-18 | 2017 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 750,000 | 912,329 | 0 | 0 | 0 | 1,662,329 |
| 2018-04-18 | 2017 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 521,674 | 521,674 | 0 | 0 | 0 | 1,043,348 |
| 2018-04-18 | 2016 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 506,480 | 1,178,304 | 0 | 0 | 0 | 1,684,784 |
| 2018-04-18 | 2015 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 450,204 | 0 | 0 | 0 | 0 | 450,204 |
| 2018-04-18 | 2017 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 579,638 | 579,638 | 88,000 | 0 | 0 | 1,247,276 |
| 2018-04-18 | 2016 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 562,755 | 1,414,571 | 0 | 0 | 0 | 1,977,326 |
| 2018-04-18 | 2015 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 546,364 | 0 | 0 | 0 | 0 | 546,364 |
| 2018-04-18 | 2016 | Robin A. Abrams General Counsel and Chief Administrative Officer (effective April 12, 2016) | 426,894 | 490,000 | 0 | 0 | 0 | 916,894 |
| 2018-04-18 | 2016 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 162,500 | 0 | 2,108,824 | 0 | 0 | 2,271,324 |
| 2018-04-18 | 2015 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) Chief Executive Officer (until October 13, 2016) | 764,909 | 0 | 0 | 0 | 0 | 764,909 |
| 2018-04-18 | 2016 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) Chief Executive Officer (until October 13, 2016) | 778,386 | 1,442,516 | 717,000 | 0 | 0 | 2,937,902 |
| 2018-04-18 | 2017 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) Chief Executive Officer (until October 13, 2016) | 732,167 | 0 | 0 | 0 | 0 | 732,167 |
| 2017-04-17 | 2014 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 437,091 | 0 | 335,000 | 0 | 0 | 772,091 |
| 2017-04-17 | 2016 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 562,755 | 1,414,571 | 0 | 0 | 0 | 1,977,326 |
| 2017-04-17 | 2015 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 546,364 | 0 | 0 | 0 | 0 | 546,364 |
| 2017-04-17 | 2014 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 530,450 | 0 | 251,250 | 0 | 0 | 781,700 |
| 2017-04-17 | 2016 | Robin A. Abrams | 426,894 | 490,000 | 0 | 0 | 0 | 916,894 |
| 2017-04-17 | 2016 | William J. Haynes Executive Vice President & General Counsel (Resigned, effective January 5, 2016) | 5,588 | 242,283 | 0 | 0 | 0 | 247,871 |
| 2017-04-17 | 2015 | William J. Haynes Executive Vice President & General Counsel (Resigned, effective January 5, 2016) | 491,727 | 0 | 0 | 0 | 0 | 491,727 |
| 2017-04-17 | 2014 | William J. Haynes Executive Vice President & General Counsel (Resigned, effective January 5, 2016) | 477,405 | 0 | 251,250 | 0 | 0 | 728,655 |
| 2017-04-17 | 2016 | Phillip L. Gomez, Ph.D. Chief Executive Officer (effective October 13, 2016) | 162,500 | 0 | 2,108,824 | 0 | 0 | 2,271,324 |
| 2017-04-17 | 2016 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) | 778,386 | 1,442,516 | 717,000 | 0 | 0 | 2,937,902 |
| 2017-04-17 | 2015 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) | 764,909 | 0 | 0 | 0 | 0 | 764,909 |
| 2017-04-17 | 2014 | Eric A. Rose, M.D. Executive Chairman of the Board (effective October 13, 2016) | 743,130 | 0 | 670,000 | 0 | 0 | 1,413,130 |
| 2017-04-17 | 2016 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 506,480 | 1,178,304 | 0 | 0 | 0 | 1,684,784 |
| 2017-04-17 | 2015 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 450,204 | 0 | 0 | 0 | 0 | 450,204 |
| 2016-04-18 | 2015 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 450,204 | 0 | 0 | 0 | 0 | 450,201 |
| 2016-04-18 | 2014 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 437,091 | 0 | 335,000 | 0 | 0 | 772,087 |
| 2016-04-18 | 2012 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 424,360 | 212,180 | 282,000 | 0 | 0 | 918,540 |
| 2016-04-18 | 2015 | William J. Haynes Executive Vice President & General Counsel | 491,727 | 0 | 0 | 0 | 0 | 491,724 |
| 2016-04-18 | 2014 | William J. Haynes Executive Vice President & General Counsel | 477,405 | 0 | 251,250 | 0 | 0 | 728,651 |
| 2016-04-18 | 2013 | William J. Haynes Executive Vice President & General Counsel | 450,000 | 225,000 | 211,500 | 0 | 0 | 886,500 |
| 2016-04-18 | 2015 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 546,364 | 0 | 0 | 0 | 0 | 546,361 |
| 2016-04-18 | 2014 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 530,450 | 0 | 251,250 | 0 | 0 | 781,696 |
| 2016-04-18 | 2013 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 515,000 | 257,500 | 211,500 | 0 | 0 | 984,000 |
| 2016-04-18 | 2015 | Eric A. Rose, M.D. Chief Executive Officer | 764,909 | 0 | 0 | 0 | 0 | 764,906 |
| 2016-04-18 | 2014 | Eric A. Rose, M.D. Chief Executive Officer | 743,130 | 0 | 670,000 | 0 | 0 | 1,413,126 |
| 2016-04-18 | 2013 | Eric A. Rose, M.D. Chief Executive Officer | 721,000 | 360,500 | 564,000 | 0 | 500 | 1,646,000 |
| 2015-04-14 | 2013 | William J. Haynes Executive Vice President & General Counsel | 450,000 | 225,000 | 211,500 | 0 | 0 | 886,500 |
| 2015-04-14 | 2014 | Eric A. Rose, M.D. Chief Executive Officer | 743,130 | 0 | 670,000 | 0 | 0 | 1,413,126 |
| 2015-04-14 | 2013 | Eric A. Rose, M.D. Chief Executive Officer | 721,000 | 360,500 | 564,000 | 0 | 500 | 1,646,000 |
| 2015-04-14 | 2012 | Eric A. Rose, M.D. Chief Executive Officer | 700,000 | 350,000 | 594,000 | 0 | 0 | 1,846,136 |
| 2015-04-14 | 2014 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 437,091 | 0 | 335,000 | 0 | 0 | 772,087 |
| 2015-04-14 | 2013 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 424,360 | 212,180 | 282,000 | 0 | 0 | 918,540 |
| 2015-04-14 | 2012 | William J. Haynes Executive Vice President & General Counsel | 260,795 | 225,000 | 0 | 0 | 0 | 643,008 |
| 2015-04-14 | 2014 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 530,450 | 0 | 251,250 | 0 | 0 | 781,696 |
| 2015-04-14 | 2013 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 515,000 | 257,500 | 211,500 | 0 | 0 | 984,000 |
| 2015-04-14 | 2012 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 500,000 | 500,000 | 222,750 | 0 | 0 | 1,409,909 |
| 2015-04-14 | 2012 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 400,000 | 200,000 | 103,950 | 0 | 0 | 901,277 |
| 2015-04-14 | 2014 | William J. Haynes Executive Vice President & General Counsel | 477,405 | 0 | 251,250 | 0 | 0 | 728,651 |
| 2014-04-15 | 2013 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 515,000 | 257,500 | 211,500 | 0 | 0 | 984,000 |
| 2014-04-15 | 2011 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 275,000 |
| 2014-04-15 | 2013 | Ayelet Dugary Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2014-04-15 | 2013 | Eric A. Rose, M.D. Chief Executive Officer | 721,000 | 360,500 | 564,000 | 0 | 500 | 1,646,000 |
| 2014-04-15 | 2012 | Ayelet Dugary Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2014-04-15 | 2012 | Eric A. Rose, M.D. Chief Executive Officer | 700,000 | 350,000 | 594,000 | 0 | 0 | 1,846,136 |
| 2014-04-15 | 2011 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 1,000,000 | 6,967,800 | 0 | 0 | 8,367,800 |
| 2014-04-15 | 2013 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 424,360 | 212,180 | 282,000 | 0 | 0 | 918,540 |
| 2014-04-15 | 2012 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 400,000 | 200,000 | 103,950 | 0 | 0 | 901,277 |
| 2014-04-15 | 2011 | Daniel J. Luckshire Executive Vice President & Chief Financial Officer | 356,061 | 200,000 | 0 | 0 | 0 | 1,433,126 |
| 2014-04-15 | 2013 | William J. Haynes Executive Vice President & | 450,000 | 225,000 | 211,500 | 0 | 0 | 886,500 |
| 2014-04-15 | 2012 | William J. Haynes Executive Vice President & | 260,795 | 225,000 | 0 | 0 | 0 | 643,008 |
| 2014-04-15 | 2012 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 500,000 | 500,000 | 222,750 | 0 | 0 | 1,409,909 |
| 2014-04-15 | 2011 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 335,803 | 350,000 | 0 | 0 | 0 | 685,803 |
| 2013-04-16 | 2011 | Daniel J. Luckshire Executive Vice President & | 356,061 | 200,000 | 0 | 0 | 0 | 1,433,126 |
| 2013-04-16 | 2012 | William J. Haynes | 260,795 | 225,000 | 0 | 0 | 0 | 643,008 |
| 2013-04-16 | 2012 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 500,000 | 500,000 | 222,750 | 0 | 0 | 1,409,909 |
| 2013-04-16 | 2011 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 1,000,000 | 6,967,800 | 0 | 0 | 8,367,800 |
| 2013-04-16 | 2010 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 275,000 |
| 2013-04-16 | 2011 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 275,000 |
| 2013-04-16 | 2012 | Ayelet Dugary Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2013-04-16 | 2010 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 425,000 |
| 2013-04-16 | 2011 | Dennis E. Hruby, Ph.D. Vice President & Chief Scientific Officer | 335,803 | 350,000 | 0 | 0 | 0 | 685,803 |
| 2013-04-16 | 2010 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 400,000 |
| 2013-04-16 | 2012 | Daniel J. Luckshire Executive Vice President & | 400,000 | 200,000 | 103,950 | 0 | 0 | 901,277 |
| 2013-04-16 | 2012 | Eric A. Rose, M.D. Chief Executive Officer | 700,000 | 350,000 | 594,000 | 0 | 0 | 1,846,136 |
| 2012-04-27 | 2009 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 355,703 |
| 2012-04-27 | 2011 | Chief Financial Officer | 356,061 | 200,000 | 0 | 0 | 0 | 814,576 |
| 2012-04-27 | 2011 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 1,000,000 | 6,967,800 | 0 | 0 | 8,432,757 |
| 2012-04-27 | 2010 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 562,441 |
| 2012-04-27 | 2009 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 881,112 |
| 2012-04-27 | 2011 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 335,803 | 350,000 | 0 | 0 | 0 | 746,755 |
| 2012-04-27 | 2010 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 536,222 |
| 2012-04-27 | 2009 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 643,773 |
| 2012-04-27 | 2011 | Ayelet Dugary Chief Financial Officer | 241,176 | 0 | 0 | 0 | 0 | 297,447 |
| 2012-04-27 | 2010 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 328,919 |
| 2011-04-12 | 2009 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 643,773 |
| 2011-04-12 | 2008 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 567,716 |
| 2011-04-12 | 2010 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 562,441 |
| 2011-04-12 | 2010 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 536,222 |
| 2011-04-12 | 2009 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 881,112 |
| 2011-04-12 | 2008 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 566,943 |
| 2011-04-12 | 2010 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 328,919 |
| 2011-04-12 | 2009 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 355,703 |
| 2011-04-12 | 2008 | Ayelet Dugary Chief Financial Officer | 180,000 | 40,000 | 0 | 0 | 0 | 266,939 |
| 2010-04-12 | 2007 | Eric A. Rose, M.D. Chief Executive Officer | 333,750 | 0 | 0 | 0 | 0 | 699,930 |
| 2010-04-12 | 2008 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 990,760 |
| 2010-04-12 | 2007 | Ayelet Dugary Chief Financial Officer | 180,000 | 40,000 | 0 | 0 | 0 | 265,773 |
| 2010-04-12 | 2009 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 275,000 | 150,000 | 0 | 0 | 0 | 560,045 |
| 2010-04-12 | 2009 | Thomas N. Konatich Former Chief Financial Officer | 40,063 | 0 | 0 | 0 | 125,000 | 165,063 |
| 2010-04-12 | 2008 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 375,000 |
| 2010-04-12 | 2008 | Thomas N. Konatich Former Chief Financial Officer | 250,000 | 60,000 | 0 | 0 | 0 | 310,000 |
| 2010-04-12 | 2007 | Thomas N. Konatich Former Chief Financial Officer | 250,000 | 60,000 | 0 | 0 | 0 | 584,635 |
| 2010-04-12 | 2007 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 924,270 |
| 2010-04-12 | 2009 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 400,000 |
| 2010-04-12 | 2008 | Ayelet Dugary Chief Financial Officer | 180,000 | 40,000 | 0 | 0 | 0 | 220,000 |
| 2010-04-12 | 2009 | Ayelet Dugary Chief Financial Officer | 225,000 | 50,000 | 0 | 0 | 0 | 410,045 |
| 2009-04-08 | 2008 | Eric A. Rose, M.D. Chief Executive Officer | 400,000 | 0 | 0 | 0 | 0 | 990,760 |
| 2009-04-08 | 2006 | Ayelet Dugary Acting Chief Financial Officer | 150,000 | 40,000 | 0 | 0 | 0 | 190,000 |
| 2009-04-08 | 2008 | Bernard L. Kasten Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2009-04-08 | 2008 | Ayelet Dugary Acting Chief Financial Officer | 180,000 | 40,000 | 0 | 0 | 0 | 220,000 |
| 2009-04-08 | 2006 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 229,166 | 174,500 | 0 | 0 | 0 | 403,666 |
| 2009-04-08 | 2007 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 924,270 |
| 2009-04-08 | 2008 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 375,000 |
| 2009-04-08 | 2006 | Thomas N. Konatich Chief Financial Officer | 233,333 | 117,500 | 0 | 0 | 0 | 350,833 |
| 2009-04-08 | 2007 | Bernard L. Kasten Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2009-04-08 | 2006 | Bernard L. Kasten Chief Executive Officer | 83,333 | 0 | 0 | 0 | 94,792 | 178,125 |
| 2009-04-08 | 2007 | Thomas N. Konatich Chief Financial Officer | 250,000 | 60,000 | 0 | 0 | 0 | 584,635 |
| 2009-04-08 | 2008 | Thomas N. Konatich Chief Financial Officer | 250,000 | 60,000 | 0 | 0 | 0 | 310,000 |
| 2009-04-08 | 2007 | Ayelet Dugary Acting Chief Financial Officer | 180,000 | 40,000 | 0 | 0 | 0 | 265,773 |
| 2009-04-08 | 2007 | Eric A. Rose, M.D. Chief Executive Officer | 333,750 | 0 | 0 | 0 | 0 | 699,930 |
| 2009-04-08 | 2006 | Eric A. Rose, M.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2008-04-09 | 2006 | Bernard L. Kasten Chief Executive Officer | 83,333 | 0 | 0 | 0 | 94,792 | 178,125 |
| 2008-04-09 | 2007 | Bernard L. Kasten Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2008-04-09 | 2006 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 229,166 | 174,500 | 0 | 0 | 0 | 403,666 |
| 2008-04-09 | 2007 | Dennis E. Hruby, Ph.D. Chief Scientific Officer | 250,000 | 125,000 | 0 | 0 | 0 | 924,270 |
| 2008-04-09 | 2005 | Thomas N. Konatich Chief Financial Officer | 230,000 | 35,000 | 0 | 0 | 0 | 265,000 |
| 2008-04-09 | 2006 | Thomas N. Konatich Chief Financial Officer | 233,333 | 117,500 | 0 | 0 | 0 | 350,833 |
| 2008-04-09 | 2007 | Thomas N. Konatich Chief Financial Officer | 250,000 | 60,000 | 0 | 0 | 0 | 584,635 |
| 2008-04-09 | 2005 | Eric A. Rose, M.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2008-04-09 | 2006 | Eric A. Rose, M.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2008-04-09 | 2005 | Bernard L. Kasten Chief Executive Officer | 250,000 | 0 | 0 | 0 | 0 | 250,000 |
| 2008-04-09 | 2007 | Eric A. Rose, M.D. Chief Executive Officer | 333,750 | 0 | 0 | 0 | 0 | 699,930 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
